Pierre Lemaitre

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.

GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.

Journal: Diabetologia
Published: December 01, 2025

Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.

Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.

Journal: Diabetologia
Published: May 28, 2025

Trub1-mediated pseudouridylation is dispensable for immune cell development and homeostasis.

Trub1-mediated pseudouridylation is dispensable for immune cell development and homeostasis.

Journal: Genes and immunity
Published: February 13, 2025

Protocol for murine multi-tissue deep immunophenotyping using a 40-color full-spectrum flow cytometry panel.

Protocol for murine multi-tissue deep immunophenotyping using a 40-color full-spectrum flow cytometry panel.

Journal: STAR protocols
Published: September 06, 2024

The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program.

The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program.

Journal: Immunity
Published: October 05, 2023

Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes.

Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes.

Journal: The Journal of clinical investigation
Published: October 05, 2023

A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.

A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.

Journal: Diabetes
Published: October 11, 2022

Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain.

Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain.

Journal: EMBO molecular medicine
Published: August 28, 2022

Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation.

Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation.

Journal: Nature immunology
Published: March 01, 2022

Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells.

Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells.

Journal: Science advances
Published: September 27, 2020

Unstable regulatory T cells, enriched for naïve and Nrp1neg cells, are purged after fate challenge.

Unstable regulatory T cells, enriched for naïve and Nrp1neg cells, are purged after fate challenge.

Journal: Science immunology
Published: August 24, 2020

Loss of the Transfer RNA Wobble Uridine-Modifying Enzyme Elp3 Delays T Cell Cycle Entry and Impairs T Follicular Helper Cell Responses through Deregulation of Atf4.

Loss of the Transfer RNA Wobble Uridine-Modifying Enzyme Elp3 Delays T Cell Cycle Entry and Impairs T Follicular Helper Cell Responses through Deregulation of Atf4.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 07, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026